Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline.

Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline. Case Rep Psychiatry. 2017;2017:1319505 Authors: Nakamura T, Sugiyama N, Sasayama D, Hagiwara T, Washizuka S Abstract Here, we report our experience with patients in whom jitteriness/anxiety syndrome developed immediately following the start of oral sertraline administration. Administration was discontinued in these patients on day 2, and the jitteriness/anxiety syndrome improved the following day. Jitteriness/anxiety syndrome may develop immediately following oral administration of even low doses of sertraline, and improvement can be expected if sertraline is promptly discontinued. PMID: 28912994 [PubMed]
Source: Case Reports in Psychiatry - Category: Psychiatry Tags: Case Rep Psychiatry Source Type: research